Advertisement
Screener

CHAMPIONS ONCOLOGY, INC. (CSBR) Operating Income

CHAMPIONS ONCOLOGY, INC. Operating Income

CHAMPIONS ONCOLOGY, INC. (CSBR) reported Operating Income of -$409.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-09-11

  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for the quarter ending 2026-07-31 was -$409.00K.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for the quarter ending 2026-04-30 was -$522.00K.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for the quarter ending 2026-01-31 was -$276.00K, a 106.13% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for the quarter ending 2025-10-31 was $185.00K, a 74.73% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for fiscal 2026 was -$1.14M, a 125.04% decline from fiscal 2025.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for fiscal 2025 was $4.55M.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for fiscal 2024 was -$7.36M.
  • CHAMPIONS ONCOLOGY, INC. operating income (loss) for fiscal 2023 was -$5.26M, a 965.90% decline from fiscal 2022.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-07-31-$409.00K
10-Q · filed 2026-09-11
-$931.00K
derived: sum of 2 quarters · filed 2026-09-11
-$1.21M
derived: sum of 3 quarters · filed 2026-09-11
-$1.02M
derived: sum of 4 quarters · filed 2026-09-11
2026-04-30-$522.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27
-$798.00K
derived: sum of 2 quarters · filed 2026-07-27
-$613.00K
derived: sum of 3 quarters · filed 2026-07-27
-$1.14M
10-K · filed 2026-07-27
2026-01-31-$276.00K
10-Q · filed 2026-03-12
-$91.00K
derived: sum of 2 quarters · filed 2026-03-12
-$618.00K
10-Q · filed 2026-03-12
-$2.63M
derived: sum of 4 quarters · filed 2026-09-11
2025-10-31$185.00K
10-Q · filed 2025-12-15
-$342.00K
10-Q · filed 2025-12-15
-$2.35M
derived: sum of 3 quarters · filed 2026-09-11
$2.15M
derived: sum of 4 quarters · filed 2026-09-11
2025-07-31-$527.00K
10-Q · filed 2026-09-11
-$2.53M
derived: sum of 2 quarters · filed 2026-09-11
$1.97M
derived: sum of 3 quarters · filed 2026-09-11
$2.70M
derived: sum of 4 quarters · filed 2026-09-11
2025-04-30-$2.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27
$2.49M
derived: sum of 2 quarters · filed 2026-07-27
$3.22M
derived: sum of 3 quarters · filed 2026-07-27
$4.55M
10-K · filed 2026-07-27
2025-01-31$4.50M
10-Q · filed 2026-03-12
$5.23M
derived: sum of 2 quarters · filed 2026-03-12
$6.56M
10-Q · filed 2026-03-12
$6.29M
derived: sum of 4 quarters · filed 2026-03-12
2024-10-31$732.00K
10-Q · filed 2025-12-15
$2.06M
10-Q · filed 2025-12-15
$1.79M
derived: sum of 3 quarters · filed 2025-12-15
-$787.00K
derived: sum of 4 quarters · filed 2025-12-15
2024-07-31$1.33M
10-Q · filed 2025-09-15
$1.06M
derived: sum of 2 quarters · filed 2025-09-15
-$1.52M
derived: sum of 3 quarters · filed 2025-09-15
-$3.47M
derived: sum of 4 quarters · filed 2025-09-15
2024-04-30-$271.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23
-$2.85M
derived: sum of 2 quarters · filed 2025-07-23
-$4.80M
derived: sum of 3 quarters · filed 2025-07-23
-$7.36M
10-K · filed 2025-07-23
2024-01-31-$2.58M
10-Q · filed 2025-03-17
-$4.53M
derived: sum of 2 quarters · filed 2025-03-17
-$7.08M
10-Q · filed 2025-03-17
-$9.61M
derived: sum of 4 quarters · filed 2025-03-17
2023-10-31-$1.96M
10-Q · filed 2024-12-16
-$4.51M
10-Q · filed 2024-12-16
-$7.03M
derived: sum of 3 quarters · filed 2024-12-16
-$9.49M
derived: sum of 4 quarters · filed 2024-12-16
2023-07-31-$2.55M
10-Q · filed 2024-09-13
-$5.07M
derived: sum of 2 quarters · filed 2024-09-13
-$7.53M
derived: sum of 3 quarters · filed 2024-09-13
-$7.52M
derived: sum of 4 quarters · filed 2024-09-13
2023-04-30-$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19
-$4.98M
derived: sum of 2 quarters · filed 2024-07-19
-$4.97M
derived: sum of 3 quarters · filed 2024-07-19
-$5.26M
10-K · filed 2024-07-19
2023-01-31-$2.46M
10-Q · filed 2024-03-15
-$2.45M
derived: sum of 2 quarters · filed 2024-03-15
-$2.73M
10-Q · filed 2024-03-15
-$3.05M
derived: sum of 4 quarters · filed 2024-03-15
2022-10-31$7.00K
10-Q · filed 2023-12-13
-$277.00K
10-Q · filed 2023-12-13
-$588.00K
derived: sum of 3 quarters · filed 2023-12-13
$242.00K
derived: sum of 4 quarters · filed 2023-12-13
2022-07-31-$284.00K
10-Q · filed 2023-09-13
-$595.00K
derived: sum of 2 quarters · filed 2023-09-13
$235.00K
derived: sum of 3 quarters · filed 2023-09-13
$498.00K
derived: sum of 4 quarters · filed 2023-09-13
2022-04-30-$311.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24
$519.00K
derived: sum of 2 quarters · filed 2023-07-24
$782.00K
derived: sum of 3 quarters · filed 2023-07-24
$607.00K
10-K · filed 2023-07-24
2022-01-31$830.00K
10-Q · filed 2023-03-16
$1.09M
derived: sum of 2 quarters · filed 2023-03-16
$918.00K
10-Q · filed 2023-03-16
$270.00K
derived: sum of 4 quarters · filed 2023-03-16
2021-10-31$263.00K
10-Q · filed 2022-12-13
$88.00K
10-Q · filed 2022-12-13
-$560.00K
derived: sum of 3 quarters · filed 2022-12-13
$422.00K
derived: sum of 4 quarters · filed 2022-12-13
2021-07-31-$175.00K
10-Q · filed 2022-09-12
-$823.00K
derived: sum of 2 quarters · filed 2022-09-12
$159.00K
derived: sum of 3 quarters · filed 2022-09-12
$166.00K
derived: sum of 4 quarters · filed 2022-09-12
2021-04-30-$648.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22
$334.00K
derived: sum of 2 quarters · filed 2022-07-22
$341.00K
derived: sum of 3 quarters · filed 2022-07-22
$366.00K
10-K · filed 2022-07-22
2021-01-31$982.00K
10-Q · filed 2022-03-15
$763.00K
10-Q · filed 2021-03-15
$989.00K
derived: sum of 2 quarters · filed 2022-03-15
$1.01M
10-Q · filed 2022-03-15
$795.00K
10-Q · filed 2021-03-15
-$1.02M
derived: sum of 4 quarters · filed 2022-03-15
2020-10-31$7.00K
10-Q · filed 2021-12-13
$31.00K
10-Q · filed 2021-12-13
-$2.00M
derived: sum of 3 quarters · filed 2021-12-13
-$1.57M
derived: sum of 4 quarters · filed 2021-12-13
2020-07-31$24.00K
10-Q · filed 2021-09-13
-$2.01M
derived: sum of 2 quarters · filed 2021-09-13
-$1.57M
derived: sum of 3 quarters · filed 2021-09-13
-$1.28M
derived: sum of 4 quarters · filed 2021-09-13
2020-04-30-$2.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26
-$1.60M
derived: sum of 2 quarters · filed 2021-07-26
-$1.31M
derived: sum of 3 quarters · filed 2021-07-26
-$1.92M
10-K · filed 2021-07-26
-$1.80M
10-K · filed 2020-07-28
2020-01-31$433.00K
10-Q · filed 2021-03-15
$724.00K
derived: sum of 2 quarters · filed 2021-03-15
$109.00K
10-Q · filed 2021-03-15
-$6.00K
derived: sum of 4 quarters · filed 2021-03-15
2019-10-31$291.00K
10-Q · filed 2020-12-14
-$323.00K
10-Q · filed 2020-12-14
-$439.00K
derived: sum of 3 quarters · filed 2020-12-14
-$809.00K
derived: sum of 4 quarters · filed 2020-12-14
2019-07-31-$614.00K
10-Q · filed 2020-09-14
-$730.00K
derived: sum of 2 quarters · filed 2020-09-14
-$1.10M
derived: sum of 3 quarters · filed 2020-09-14
-$825.00K
derived: sum of 4 quarters · filed 2020-09-14
2019-04-30-$116.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28
-$486.00K
derived: sum of 2 quarters · filed 2020-07-28
-$211.00K
derived: sum of 3 quarters · filed 2020-07-28
$270.00K
10-K · filed 2020-07-28
2019-01-31-$370.00K
10-Q · filed 2020-03-16
-$95.00K
derived: sum of 2 quarters · filed 2020-03-16
$386.00K
10-Q · filed 2020-03-16
-$213.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-10-31$275.00K
10-Q · filed 2019-12-16
$757.00K
10-Q · filed 2019-12-16
$157.00K
derived: sum of 3 quarters · filed 2019-12-16
$90.00K
derived: sum of 4 quarters · filed 2019-12-16
2018-07-31$481.00K
10-Q · filed 2019-09-16
-$118.00K
derived: sum of 2 quarters · filed 2019-09-16
-$185.00K
derived: sum of 3 quarters · filed 2019-09-16
-$255.00K
derived: sum of 4 quarters · filed 2019-09-16
2018-04-30-$599.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29
-$666.00K
derived: sum of 2 quarters · filed 2019-07-29
-$736.00K
derived: sum of 3 quarters · filed 2019-07-29
-$1.35M
10-K · filed 2019-07-29
2018-01-31-$67.00K
10-Q · filed 2019-03-18
-$137.00K
derived: sum of 2 quarters · filed 2019-03-18
-$755.00K
10-Q · filed 2019-03-18
-$3.15M
derived: sum of 4 quarters · filed 2019-03-18
2017-10-31-$70.00K
10-Q · filed 2018-12-17
-$689.00K
10-Q · filed 2018-12-17
-$3.08M
derived: sum of 3 quarters · filed 2018-12-17
-$4.48M
derived: sum of 4 quarters · filed 2018-12-17
2017-07-31-$619.00K
10-Q · filed 2018-09-14
-$3.01M
derived: sum of 2 quarters · filed 2018-09-14
-$4.41M
derived: sum of 3 quarters · filed 2018-09-14
-$4.90M
derived: sum of 4 quarters · filed 2018-09-14
2017-04-30-$2.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30
-$3.79M
derived: sum of 2 quarters · filed 2018-07-30
-$4.28M
derived: sum of 3 quarters · filed 2018-07-30
-$6.81M
10-K · filed 2018-07-30
2017-01-31-$1.40M
10-Q · filed 2018-03-19
-$1.89M
derived: sum of 2 quarters · filed 2018-03-19
-$4.42M
10-Q · filed 2018-03-19
-$6.97M
derived: sum of 4 quarters · filed 2018-03-19
2016-10-31-$493.00K
10-Q · filed 2017-12-15
-$3.02M
10-Q · filed 2017-12-15
-$5.57M
derived: sum of 3 quarters · filed 2017-12-15
-$7.94M
derived: sum of 4 quarters · filed 2017-12-15
2016-07-31-$2.52M
10-Q · filed 2017-09-14
-$5.07M
derived: sum of 2 quarters · filed 2017-09-14
-$7.45M
derived: sum of 3 quarters · filed 2017-09-14
-$9.94M
derived: sum of 4 quarters · filed 2017-09-14
2016-04-30-$2.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28
-$4.92M
derived: sum of 2 quarters · filed 2017-07-28
-$7.42M
derived: sum of 3 quarters · filed 2017-07-28
-$10.32M
10-K · filed 2017-07-28
2016-01-31-$2.37M
10-Q · filed 2017-03-17
-$4.87M
derived: sum of 2 quarters · filed 2017-03-17
-$7.77M
10-Q · filed 2017-03-17
-$10.17M
derived: sum of 4 quarters · filed 2017-03-17
2015-10-31-$2.49M
10-Q · filed 2016-12-14
-$5.39M
10-Q · filed 2016-12-14
-$7.79M
derived: sum of 3 quarters · filed 2016-12-14
-$11.21M
derived: sum of 4 quarters · filed 2016-12-14
2015-07-31-$2.90M
10-Q · filed 2016-09-14
-$5.30M
derived: sum of 2 quarters · filed 2016-09-14
-$8.72M
derived: sum of 3 quarters · filed 2016-09-14
-$12.39M
derived: sum of 4 quarters · filed 2016-09-14
2015-04-30-$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29
-$5.82M
derived: sum of 2 quarters · filed 2016-07-29
-$9.49M
derived: sum of 3 quarters · filed 2016-07-29
-$13.24M
10-K · filed 2016-07-29
2015-01-31-$3.42M
10-Q · filed 2016-03-16
-$7.08M
derived: sum of 2 quarters · filed 2016-03-16
-$10.83M
10-Q · filed 2016-03-16
-$13.19M
derived: sum of 4 quarters · filed 2016-03-16
2014-10-31-$3.67M
10-Q · filed 2015-12-15
-$7.39M
10-Q · filed 2015-12-15
-$9.77M
derived: sum of 3 quarters · filed 2015-12-15
-$11.18M
derived: sum of 4 quarters · filed 2015-12-15
2014-07-31-$3.73M
10-Q · filed 2015-09-11
-$6.11M
derived: sum of 2 quarters · filed 2015-09-11
-$7.51M
derived: sum of 3 quarters · filed 2015-09-11
-$9.22M
derived: sum of 4 quarters · filed 2015-09-11
2014-04-30-$2.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29
-$3.79M
derived: sum of 2 quarters · filed 2015-07-29
-$5.49M
derived: sum of 3 quarters · filed 2015-07-29
-$6.26M
10-K · filed 2015-07-29
2014-01-31-$1.41M
10-Q · filed 2015-03-17
-$3.11M
derived: sum of 2 quarters · filed 2015-03-17
-$3.88M
10-Q · filed 2015-03-17
-$5.86M
derived: sum of 4 quarters · filed 2015-03-17
2013-10-31-$1.70M
10-Q · filed 2014-12-15
-$2.47M
10-Q · filed 2014-12-15
-$4.45M
derived: sum of 3 quarters · filed 2014-12-15
-$5.17M
derived: sum of 4 quarters · filed 2014-12-15
2013-07-31-$766.00K
10-Q · filed 2014-09-12
-$2.75M
derived: sum of 2 quarters · filed 2014-09-12
-$3.47M
derived: sum of 3 quarters · filed 2014-09-12
-$5.39M
derived: sum of 4 quarters · filed 2014-09-12
2013-04-30-$1.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28
-$2.71M
derived: sum of 2 quarters · filed 2014-07-28
-$4.62M
derived: sum of 3 quarters · filed 2014-07-28
-$6.22M
10-K · filed 2014-07-28
2013-01-31-$720.00K
10-Q · filed 2014-03-14
-$2.64M
derived: sum of 2 quarters · filed 2014-03-14
-$4.24M
10-Q · filed 2014-03-14
-$6.84M
derived: sum of 4 quarters · filed 2014-03-14
2012-10-31-$1.92M
10-Q · filed 2013-12-13
-$3.52M
10-Q · filed 2013-12-13
-$6.12M
derived: sum of 3 quarters · filed 2013-12-13
-$7.89M
derived: sum of 4 quarters · filed 2013-12-13
2012-07-31-$1.60M
10-Q · filed 2013-09-13
-$4.20M
derived: sum of 2 quarters · filed 2013-09-13
-$5.97M
derived: sum of 3 quarters · filed 2013-09-13
-$8.44M
derived: sum of 4 quarters · filed 2013-09-13
2012-04-30-$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26
-$4.38M
derived: sum of 2 quarters · filed 2013-07-26
-$6.84M
derived: sum of 3 quarters · filed 2013-07-26
-$9.06M
10-K · filed 2013-07-26
2012-01-31-$1.77M
10-Q · filed 2013-03-13
-$4.24M
derived: sum of 2 quarters · filed 2013-03-13
-$6.46M
10-Q · filed 2013-03-13
-$9.29M
derived: sum of 4 quarters · filed 2013-03-13
2011-10-31-$2.47M
10-Q · filed 2012-12-13
-$4.68M
10-Q · filed 2012-12-13
-$7.52M
derived: sum of 3 quarters · filed 2012-12-13
-$8.31M
derived: sum of 4 quarters · filed 2012-12-13
2011-07-31-$2.21M
10-Q · filed 2012-09-12
-$5.05M
derived: sum of 2 quarters · filed 2012-09-12
-$5.84M
derived: sum of 3 quarters · filed 2012-09-12
-$6.85M
derived: sum of 4 quarters · filed 2012-09-12
2011-04-30-$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18
-$3.63M
derived: sum of 2 quarters · filed 2012-07-18
-$4.64M
derived: sum of 3 quarters · filed 2012-07-18
-$5.24M
10-K · filed 2012-07-18
2011-01-31-$786.00K
10-Q · filed 2012-03-14
-$1.80M
derived: sum of 2 quarters · filed 2012-03-14
-$2.40M
10-Q · filed 2012-03-14
2010-10-31-$1.01M
10-Q · filed 2011-12-14
-$1.61M
10-Q · filed 2011-12-14
2010-07-31-$603.00K
10-Q · filed 2011-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioStem Technologies, Inc. (BSEM)United States$0.069B
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Vaxart, Inc. (VXRT)United States$0.080B3.84
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48